SCHEMBL4430202

SCHEMBL4430202

[CH2]C(O)(CC(C)(C)c1ccccc1)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.44
NR3C2 P08235 4/20 0.43
NR3C1 P04150 4/20 0.43
PGR P06401 3/20 0.43
NR1H2 P55055 4/20 0.40
NR1H3 Q13133 4/20 0.40
SHBG P04278 1/20 0.37
ALDH1A1 P00352 2/20 0.37
TSHR P16473 1/20 0.37
HSD11B1 P28845 1/20 0.37
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP3A4 P08684 1/20 0.35
ALOX15 P16050 1/20 0.35
PDK1 Q15118 2/20 0.35
PDK2 Q15119 2/20 0.35
PDK3 Q15120 2/20 0.35
PDK4 Q16654 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4452422 0.82 NR3C1 (0.49) NR3C2NR3C1PGRCYP3A4
SCHEMBL3658512 0.81 CYP2C19 (0.41) NR3C2NR1H2NR1H3ALDH1A1TSHR
SCHEMBL4430210 0.78 PDK1 (0.43) TAAR1NR3C2NR1H2ALDH1A1SMN1; SMN2
SCHEMBL3684124 0.77 CYP19A1 (0.36) NR3C2NR3C1PGRNR1H2NR1H3
SCHEMBL3653019 0.76 NR3C1 (0.35) NR3C2NR3C1PGRNR1H2NR1H3
SCHEMBL3530975 0.76 NR3C1 (0.51) TAAR1NR3C2NR3C1PGRSHBG
SCHEMBL3658752 0.76 NR3C1 (0.34) NR3C2NR3C1PGRNR1H2NR1H3
SCHEMBL14158802 0.76 L3MBTL1 (0.45) ALDH1A1CYP3A4PDK2
SCHEMBL21245467 0.76 TAAR1 (0.54) TAAR1NR3C2NR3C1PGRSHBG
SCHEMBL28013950 0.76 TAAR1 (0.54) TAAR1SHBGALDH1A1CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061444-A2 COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, AMELIORATING, OR PREVENTING ALLERGY Bausch & Lomb Incorporated (US) 2009-05-27 EP disclosed
EP-2056799-A2 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GLAUCOMA OR PROGRESSION THEREOF Bausch & Lomb Incorporated (US) 2009-05-13 EP disclosed
WO-2008033655-A2 COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, AMELIORATING, OR PREVENTING ALLERGY BAUSCH & LOMB INCORPORATED (US) 2008-03-20 WO disclosed
WO-2008027796-A2 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GLAUCOMA OR PROGRESSION THEREOF BAUSCH & LOMB INCORPORATED (US) 2008-03-06 WO disclosed